Close Menu

Tech Review highlights a test from Adnavance that can detect methicillin-resistant Staphylococcus aureus without culturing the bacteria or amplifying the DNA. Instead, the Adnavance test is built on top of a gold electrode that is covered with a proprietary marker. The marker binds MRSA and when a current flows through the gold electrode, it attracts the DNA. CEO Randy White says they plan to launch the test in 2011 at a price of about $60.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.